Veranstaltungen
How will the strained Switzerland – EU relations affect Swiss life science ventures?
Technologiepark Basel AG
Relations between Switzerland and the European Union have considerably cooled during the past months. The first to suffer individual, adverse consequences in terms of market access is the medtech sector. However, other life science ventures (biotech, pharma) may also be affected in the near future. The event will provide an overview of what to watch out for.
The webinar will include a Q&A part with the opportunity to discuss individual situations and questions. Please submit your questions beforehand here to allow the speakers to prepare.
When: Thursday, 29.04.2021, 13:00 – 14.15
Where: Online
Language: English
Participation is free, however registration is required before April 29, 2021, 12pm. You will receive the link to the event after your registration has been confirmed. Follow this link to register.
Programme
13:00 Welcome
Mitja Messerli, Marketing & Stakeholder Relations Technologiepark Basel
13.05 How will the strained Switzerland – relation affect Swiss life science ventures?
Remus Muresan, Dr. iur., owner of Muresan | Legal
13.45 Closing
Heike Bihlmann, Swiss Biotech Association, Liason Basel
13.50 Q&A
14.15 End
- Datum & Zeit
-
Do. 29. April 2021
13:00 - 14:15 Uhr
- Veranstaltungsort
-
Online
- Kontakt
Technologiepark Basel AG
Mitja Messerli
Mitja.messerli@bs.ch